Concurrent Investment Advisors LLC Purchases 3,675 Shares of CME Group Inc. $CME

Concurrent Investment Advisors LLC lifted its position in CME Group Inc. (NASDAQ:CME) by 5.1% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 75,674 shares of the financial services provider’s stock after purchasing an additional 3,675 shares during the period. Concurrent Investment Advisors LLC’s holdings in CME Group were worth $16,711,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of CME. Whipplewood Advisors LLC boosted its position in CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership purchased a new stake in shares of CME Group during the 4th quarter valued at about $27,000. Hilton Head Capital Partners LLC purchased a new stake in shares of CME Group during the 4th quarter valued at about $28,000. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of CME Group during the 2nd quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID lifted its stake in shares of CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Activity at CME Group

In other CME Group news, Director William Shepard acquired 325 shares of the company’s stock in a transaction dated Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.30% of the stock is owned by insiders.

CME Group Stock Performance

Shares of NASDAQ CME opened at $281.29 on Friday. The firm has a fifty day moving average price of $258.76 and a 200-day moving average price of $278.38. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market cap of $101.15 billion, a PE ratio of 23.86, a price-to-earnings-growth ratio of 3.33 and a beta of 0.24. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. CME Group’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.96 EPS. Equities analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Wednesday, September 9th. CME Group’s payout ratio is presently 44.11%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CME shares. Barclays dropped their price objective on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, July 9th. UBS Group decreased their price target on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. The Goldman Sachs Group dropped their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research note on Tuesday, June 30th. Raymond James Financial reissued an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research report on Thursday, July 2nd. Finally, Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a report on Thursday, June 18th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, CME Group has an average rating of “Hold” and an average target price of $289.75.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.